Skip to content Skip to menu Skip to footer

Panel Perspective: Overlooked Cardiac Risk in Value-Based Care | Finding Undiagnosed Arrhythmias Across T2D, CKD, CAD, and COPD Populations

Webinar

This complimentary webinar is brought to you by

Patients with type 2 diabetes, CKD, CAD, and COPD often carry elevated cardiovascular risk that may not be fully visible in standard care pathways. For value-based care organizations, undiagnosed arrhythmias in these high-burden populations may represent an overlooked opportunity to better understand risk, improve care coordination, and address avoidable utilization.

In this webinar, leaders from health economics, clinical programs, and population health will discuss real-world examples, emerging evidence, and recent initiatives examining the intersection of chronic disease burden and arrhythmia detection. The conversation will explore where cardiac risk may be missed today, the potential clinical and economic implications of undiagnosed arrhythmias, and how proactive identification may fit into broader strategies for improving outcomes, managing risk, and advancing value-based care performance.

Disclaimers: Patient identification models and algorithms are not part of the Zio service .This webinar is for educational purposes only and does not promote any specific medical device or treatment. Clinical and economic considerations discussed may vary and should be interpreted in the context of applicable guidelines and individual patient needs. MKT2542.01

 

Topics at a Glance

  • Recent research findings on cardiac rhythm conditions in comorbid patients

  • Common reasons cardiac rhythm conditions go undetected

  • Potential savings monitoring comorbid cohorts can realize

  • Clinical perspective on how proactive cardiac monitoring programs impact outcomes

  • Operational perspective on utilizing machine-learning algorithms and EHR data to target populations

 

Who Should Attend

  • Value-based care leaders and executives

  • Population health and care management leaders

  • Clinical program directors

  • Quality, risk adjustment, and performance improvement teams

  • Health economics, actuarial, and utilization management leaders

  • Cardiologists, primary care leaders, and chronic disease program stakeholders

  • Data analytics, informatics, and EHR strategy teams

 

Top Reasons to Attend

  • Identify where arrhythmia risk may be missed across high-burden T2D, CKD, CAD, and COPD populations.

  • Explore emerging evidence on the clinical and economic impact of undiagnosed cardiac rhythm conditions in value-based care.

  • Understand how proactive cardiac monitoring programs may support earlier detection, care coordination, and risk management.

  • Evaluate opportunities to reduce avoidable utilization by targeting comorbid populations with elevated cardiovascular risk.

  • Learn how machine-learning algorithms and EHR data can help prioritize patients for cardiac monitoring initiatives.

Speakers

Register Now